Belly draining obesity treatment firm raises $5M

Aspire Bariatrics — a medical device company developing a new way to treat obesity — has raised $5 million in a private stock sale, according to documents filed with the Securities and Exchange Commission...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.